首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Effect of beta-lactamase inhibitors on the activities of various beta-lactam agents against anaerobic bacteria.
【2h】

Effect of beta-lactamase inhibitors on the activities of various beta-lactam agents against anaerobic bacteria.

机译:β-内酰胺酶抑制剂对各种β-内酰胺类药物抗厌氧菌活性的影响。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The in vitro activities of several new beta-lactam-beta-lactamase inhibitor combinations (piperacillin plus tazobactam, ceftizoxime and cefonicid with sulbactam and clavulanic acid, and ampicillin plus 8 micrograms of sulbactam per ml) were tested with anaerobic bacteria and compared with known beta-lactam-beta-lactamase inhibitor combinations and other potent antianaerobe agents. All the combinations tested (except for the cefonicid-inhibitor combinations) were active against almost all strains of the Bacteroides fragilis group. This report indicates that beta-lactamase inhibitors may improve the activity of beta-lactam agents with marginal activity against the B. fragilis group.
机译:用厌氧菌测试了几种新的β-内酰胺-β-内酰胺酶抑制剂组合(哌拉西林加他唑巴坦,头孢唑肟和头孢尼啶与舒巴坦和克拉维酸,氨苄西林加8微克舒巴坦的毫升/毫升)的体外活性,并与已知的β进行比较-内酰胺-β-内酰胺酶抑制剂组合和其他有效的抗厌氧菌剂。所有测试的组合(除头孢烯酮-抑制剂组合外)均对脆弱拟杆菌的几乎所有菌株均具有活性。该报告表明,β-内酰胺酶抑制剂可能会提高β-内酰胺类药物的活性,而对脆弱脆弱芽孢杆菌群的作用很小。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号